"...do folks think the papers Dr J aims to get pub
Post# of 148110
My opinion is as useless as anyone else's, so I'll share. Good news on the benefits of the molecule does not appear to significantly/permanently move the share price. I believe only industry movement on positive data will significantly move the needle. We've had WAY too many false alarms for movement based on overall flawed studies of the past, which is what the upcoming papers are being based on, if my understanding is correct. We may get a bump with the papers being released, but the price will likely be dragged back down as in the past. The papers themselves? No! Positive industry reaction? Absolutely. FWIW